Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 4B (C4B) is a central protein of the classical and lectin complement pathways, encoded by the C4B gene. Upon activation, the C4 protein is cleaved to produce the fragment C4b, which covalently attaches to pathogen and altered self-cells. C4b acts as an opsonin, enabling marked cells to be cleared by immune cells, and provides a scaffold for the formation of the C3 and C5 convertases that mediate further complement activation. Deficiency in C4B is associated with a predisposition to autoimmune diseases (notably systemic lupus erythematosus), while abnormal activity or regulation can contribute to inflammatory conditions. C4b is not an enzyme or receptor but is a functional protein fragment critical for opsonization and immune complex clearance.
Acts as an opsonin, marking pathogens and altered self-cells for phagocytosis. Platform for assembly of C3 and C5 convertases, enabling downstream complement activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component 4B (C4B).